Simeprevir (TMC435; TMC435350) sodium 是一种口服的、有效的和高度特异性的丙型肝炎病毒 (HCV) NS3/4A 蛋白酶抑制剂，Ki 为 0.36 nM。
| Cas No. | 1241946-89-3 |
| 别名 | 西咪匹韦钠; TMC435 sodium; TMC435350 sodium |
| Canonical SMILES | O=C(NS(C1CC1)(=O)=O)[C@]([C@]2([H])/C=C\CCCCN(C)C([C@@]3([H])[C@@]4([H])C[C@@H](OC5=CC(C6=NC(C(C)C)=CS6)=NC7=C5C=CC(OC)=C7C)C3)=O)(C2)NC4=O.[Na] |
| 分子式 | C38H47N5O7S2•XNa |
| 分子量 | 749.9 |
| 溶解度 | DMF: 30 mg/ml,DMSO: 30 mg/ml,DMSO:PBS (pH 7.2) (1:2): 0.33 mg/ml,Ethanol: slightly soluble |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Simeprevir is an orally bioavailable and potent inhibitor of the hepatitis C virus (HCV) nonstructural protein 3/4A (NS3/4A) protease (Ki = 0.36 nM), a serine protease essential for HCV replication. It inhibits HCV viral replication with an EC50 value of 7.8 nM in Huh7 replicon cells using a luciferase-based assay. Simeprevir is effective against the HCV genotypes 1a and 1b in biochemical assays. In Huh7 replicon cells, it is synergistically effective when used in combination with IFN-α or NM-107 and has an additive effect when used with ribavirin . Formulations containing simeprevir have been used, alone or in combination with pegylated IFN-α and ribavirin, for the treatment of HCV. |
